Long Grove Drug Patent Portfolio
Long Grove owns 1 orange book drug protected by 7 US patents Given below is the list of Long Grove's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10159657 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US10226436 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US10420735 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US10568850 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US11413259 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US11602508 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US12245996 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
Latest Legal Activities on Long Grove's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Long Grove.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 26 Jun, 2024 | US10888534 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 25 Aug, 2023 | US10568850 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 24 Mar, 2023 | US10420735 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 14 Mar, 2023 | US11602508 |
|
Recordation of Patent Grant Mailed
Critical
| 14 Mar, 2023 | US11602508 |
| Mail Post Card | 09 Mar, 2023 | US11602508 |
|
Email Notification
Critical
| 01 Mar, 2023 | US11602508 |
|
Email Notification
Critical
| 23 Feb, 2023 | US11602508 |
|
Issue Notification Mailed
Critical
| 22 Feb, 2023 | US11602508 |
| Dispatch to FDC | 10 Feb, 2023 | US11602508 |
|
Application Is Considered Ready for Issue
Critical
| 10 Feb, 2023 | US11602508 |
|
Mail Notice of Allowance
Critical
| 06 Feb, 2023 | US11602508 |
|
Issue Fee Payment Verified
Critical
| 06 Feb, 2023 | US11602508 |
|
Issue Fee Payment Received
Critical
| 06 Feb, 2023 | US11602508 |
|
Notice of Allowance Data Verification Completed
Critical
| 01 Feb, 2023 | US11602508 |
Long Grove's Family Patents
Long Grove Drug List
Given below is the complete list of Long Grove's drugs and the patents protecting them.
1. Norepinephrine Bitartrate In 0.9% Sodium Chloride
Norepinephrine Bitartrate In 0.9% Sodium Chloride is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10159657 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(12 years from now)
| Active |
| US10226436 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(12 years from now)
| Active |
| US10420735 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(12 years from now)
| Active |
| US10568850 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(12 years from now)
| Active |
| US11413259 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(12 years from now)
| Active |
| US11602508 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(12 years from now)
| Active |
| US12245996 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norepinephrine Bitartrate In 0.9% Sodium Chloride's drug page